Hyperhomocysteinemia-induced oxidative stress differentially alters proteasome composition and activities in heart

Faouzia Derouiche1, Christine Bôle-Feysot2, Dalila Naïmi3

  • 1Laboratory of Microbiological Engineering and Application (team of cellular physiology and molecular biology), Constantine University 1, Constantine, Algeria; Khenchela University, Khenchela, Algeria.

Insights

Hyperhomocysteinemia induces oxidative stress and damages tissues. This leads to altered proteasome function and composition, with accumulating ubiquitinated proteins, impacting cellular health.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • Hyperhomocysteinemia (HHcy) is linked to cardiovascular diseases.
  • HHcy is implicated in endogenous oxidative stress and cellular damage.
  • The proteasome system degrades oxidized proteins and regulates oxidative stress response.

Purpose of the Study:

  • To investigate if HHcy induces oxidative stress in rat heart and aorta.
  • To determine the impact of HHcy on proteasome function and composition.
  • To explore the relationship between oxidative stress and proteasome alterations in HHcy.

Main Methods:

  • Induced HHcy in male Wistar rats via dl-homocysteine injections.
  • Measured oxidative stress biomarkers (MDA, PC, SOD, CAT) and assessed tissue damage histologically.
  • Quantitated proteasome activities and evaluated ubiquitinated proteins and proteasome subunits using SDS-PAGE and Western blot.

Main Results:

  • Increased MDA and PC levels, decreased SOD and CAT levels in plasma, heart, and aorta, with observed histological changes.
  • Significant decrease in proteasome activity in the heart, but not in the aorta.
  • Altered proteasome composition in both heart and aorta, evidenced by the accumulation of ubiquitinated proteins.

Conclusions:

  • HHcy causes oxidative stress, leading to accumulating oxidized and ubiquitinated proteins.
  • The ubiquitin-proteasome system is altered in HHcy.
  • Further research is needed to elucidate the mechanisms behind proteasome alterations in HHcy.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
750
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
751
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801